Opinion

Video

CONTACT-03: Atezolizumab Plus Cabozantinib in Advanced RCC

Experts on advanced RCC discuss the CONTACT-03 trial evaluating atezolizumab plus cabozantinib following immune checkpoint inhibitor treatment in patients with inoperable disease.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.